The Danish Competition Authority approves a merger between two national pharmaceutical companies subject to conditions (Orifarm / Takeda)

The Danish Competition Council has approved Orifarm’s acquisition of certain assets from Takeda subject to commitments* The Danish Competition Council has approved Orifarm Generics Holding’s (hereinafter “Orifarm”) acquisition of certain assets, including a product portfolio consisting of prescription pharmaceuticals, over-the-counter pharmaceuticals, vitamin and

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteur

Citation

Danish Competition Authority, The Danish Competition Authority approves a merger between two national pharmaceutical companies subject to conditions (Orifarm / Takeda), 24 mars 2021, e-Competitions February 2021, Art. N° 99885

Visites 215

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues